CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −599 | $525.08 | $315K | 49,414 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −876 | $526.27 | $461K | 48,538 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,515 | $527.30 | $799K | 47,023 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,241 | $528.31 | $656K | 45,782 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,950 | $529.32 | $1.0M | 43,832 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,608 | $530.20 | $853K | 42,224 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,431 | $531.20 | $760K | 40,793 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $531.90 | $128K | 40,553 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $532.90 | $21K | 40,513 |
| 2026-03-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 107,000 | ||
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −753 | $527.47 | $397K | 52,719 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,439 | $528.41 | $760K | 51,280 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,808 | $529.82 | $1.5M | 48,472 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,776 | $530.63 | $942K | 46,696 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −794 | $531.62 | $422K | 45,902 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −650 | $532.50 | $346K | 45,252 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −80 | $533.41 | $43K | 45,172 |
| 2026-03-19 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 25,200 |
Page 144 of 171 · 3,408 trades